Abstract:The family of NF-κB transcriptional activators controls the expression of many genes, including those involved in cell survival and development. The family consists of homo- and heterodimers constituted by combinations of five subunits. Subunit p50 includes 13 tyrosine residues, but the relationship between specific tyrosine phosphorylations and p50 function is not well understood. Subunits of p50 and p65 prepared in vitro formed a heterodimer, but this NF-κB would not bind to the interleukin-2 (IL-2) promoter DNA. Treatment of p50 with guanosine triphosphate (GTP) and a lysate from activated Jurkat cells, effected rapid p50 phosphorylation, and, in the presence of wild-type subunit p65, was accompanied on the same time scale by IL-2 promoter DNA binding. Modified p50s containing one of seven stoichiometrically phosphorylated tyrosines in NF-κB p50/p65 heterodimers, included three that facilitated binding to the IL-2 DNA promoter region to a greater extent than the wild type. One of these three stoichiometrically phosphorylated p50/p65 heterodimers of NF-κB, containing pTyr60 in the p50 subunit, was treated with a lysate from activated Jurkat cells + GTP and shown to be phosphorylated on the same time scale as wild-type p50. This modified NF-κB also developed IL-2 promoter DNA binding activity on the same time scale as the wild type but exhibited greater binding to the IL-2 DNA promoters than the wild type. The nature of this enhanced binding was studied in greater detail using a metabolically stable pTyr derivative at position 60 of p50 and cellular phosphatases. We suggest that enhanced DNA binding of modified NF-κB containing pTyr60 in the p50 subunit may reflect stoichiometric NF-κB phosphorylation at a site that is not normally fully phosphorylated, or not phosphorylated at all, and is relatively resistant to the effects of Jurkat cell tyrosine phosphatase activity. This conclusion was reinforced by demonstrating that modification of Tyr60 of p50 with a metabolically stable methylenephosphonate moiety further increased the stability of the formed NF-κB p50/p65 heterodimer against the action of activated Jurkat cell phosphatases.

Post-activation Turn-off of NF-κB-dependent Transcription Is Regulated by Acetylation of p65

Repression of Gene Expression by Unphosphorylated Nf-Kappa B P65 Through Epigenetic Mechanisms

Distinct Roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in Nuclear Receptor Transactivation.

Acetylation of p65 at lysine 314 is important for late NF-κB-dependent gene expression

Single-molecule dynamics and genome-wide transcriptomics reveal that NF-kB (p65)-DNA binding times can be decoupled from transcriptional activation

Site-Selective Tyrosine Phosphorylation in the Activation of the p50 Subunit of NF-κB for DNA Binding and Transcription

MafK positively regulates NF-κB activity by enhancing CBP-mediated p65 acetylation

The Acetyltransferase HAT1 Moderates the NF-κB Response by Regulating the Transcription Factor PLZF

Krüppel-like Factor 6 Is a Co-activator of NF-κB That Mediates p65-dependent Transcription of Selected Downstream Genes

Enhancement of Nuclear Factor-κB Acetylation by Coactivator P300 and HIV-1 Tat Proteins

Regulation of Inducible Nitric Oxide Synthase Expression by P300 and P50 Acetylation.

Up-Regulation Of P300 Binding And P50 Acetylation In Tumor Necrosis Factor-Alpha-Induced Cyclooxygenase-2 Promoter Activation

Histone deacetylase 5 deacetylates the phosphatase PP2A for positively regulating NF-κB signaling

Phosphorylation of RelA/p65 on Serine 536 Defines an IκBα-independent NF-κB Pathway*

PRMT5 Dimethylates R30 of the P65 Subunit to Activate NF-κB

Up-regulation of p300 Binding and p50 Acetylation in Tumor Necrosis Factor-α-induced Cyclooxygenase-2 Promoter Activation

HDAC-mediated Deacetylation of NF-κB is Critical for Schwann Cell Myelination

Abstract 568: Identification of Novel Pre-translational Regulatory Mechanisms for NF-?B Activation

Transcriptional repression of NFKBIA triggers constitutive IKK‐ and proteasome‐independent p65/RelA activation in senescence

Selective Regulation of a Defined Subset of Inflammatory and Immunoregulatory Genes by an NF-κB p50-IκBζ Pathway

Control of NF-κB subunits by ubiquitination